Hyperlipidemia in older adults

Clin Geriatr Med. 2009 Nov;25(4):591-606, vii. doi: 10.1016/j.cger.2009.08.001.

Abstract

Older adults carry the highest risk for coronary artery disease and the highest burden of atherosclerosis. Although most clinical trials of cholesterol-lowering therapy have not specifically targeted older persons, growing evidence supports treatment of elevated low-density lipoprotein cholesterol levels in older patients, especially those at high risk for coronary events. The decision to treat a high or high-normal cholesterol level in an elderly individual must be individualized based on chronologic and physiologic age. This article summarizes current data on lipid-lowering therapy in older adults and the management of hyperlipidemia in elderly patients.

Publication types

  • Review

MeSH terms

  • Aged
  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Cholesterol, LDL / blood
  • Combined Modality Therapy
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / prevention & control*
  • Diet, Fat-Restricted
  • Dietary Fiber / administration & dosage
  • Exercise
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / epidemiology
  • Life Style
  • Randomized Controlled Trials as Topic

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Dietary Fiber
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors